Compound information
- Natural Products
- ZC2759188
- Molecular Formula
- C22H19FN6OS
- Molecular Weight
- 434.132508448 g/mol
- Structure
-
- IUPAC Name
- N-(4-fluorophenyl)-4-(3-phenylisothiazolo[4,5-d]pyrimidin-7-yl)piperazine-1-carboxamide
- InChI
- InChI=1S/C22H19FN6OS/c23-16-6-8-17(9-7-16)26-22(30)29-12-10-28(11-13-29)21-20-19(24-14-25-21)18(27-31-20)15-4-2-1-3-5-15/h1-9,14H,10-13H2,(H,26,30)
- InChI Key
- AKQHEDWWRGNKFW-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc(F)cc1)N1CCN(c2ncnc3c(-c4ccccc4)nsc23)CC1
- Source
- ZINC000001370729
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 31 | Ring Count | 5 |
| Heteroatom Count | 9 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 74.25 Å2 | LogP | 4.327 |
| LogS | -5.731 | LogD | 4.14 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.998 | Pgp substrate | 0.055 |
| HIA | 0.961 | F20 % | 0.992 |
| F30 % | 0.971 | Caco-2 | -5.052 |
| MDCK | -4.822 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.083 | PPB | 99.524 |
| VD | 1.444 | Fu | 1.633 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.991 | CYP1A2 substrate | 0.791 |
| CYP2A6 substrate | 0.228 | CYP2B6 substrate | 0.552 |
| CYP2C19 inhibitor | 0.938 | CYP2C19 substrate | 0.439 |
| CYP2C8 substrate | 0.611 | CYP2C9 inhibitor | 0.969 |
| CYP2C9 substrate | 0.954 | CYP2D6 inhibitor | 0.022 |
| CYP2D6 substrate | 0.971 | CYP2E1 substrate | 0.159 |
| CYP3A4 inhibitor | 0.634 | CYP3A4 substrate | 1.0 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.349 | CL | 4.735 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.838 | Hepatotoxicity | 0.961 |
| Mutagenicity | 0.02 | Rat Oral Acute Toxicity | 0.061 |
| FDAMDD | 0.793 | Skin Sensitization | 0.005 |
| Carcinogenicity | 0.941 | Eye Corrosion | 0.002 |
| Eye Irritation | 0.001 | Respiratory Toxicity | 0.741 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.861 | IGC50 | 4.238 |
| LC50FM | -16.132 | LC50DM | -6.898 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.729 | NR-AR-LBD | 0.738 |
| NR-AhR | 0.969 | NR-Aromatase | 0.22 |
| NR-ER | 0.703 | NR-ER-LBD | 0.501 |
| NR-PPAR-gamma | 0.932 | SR-ARE | 0.908 |
| SR-ATAD5 | 0.916 | SR-HSE | 0.296 |
| SR-MMP | 0.928 | SR-p53 | 0.936 |
Similar covalent drugs
No similar covalent drugs found for this compound.